top of page
ENGINEERED PLANT DERIVED EXOSOMES OUTPERFORM EXISTING DELIVERY SYSTEMS
Biocompatible | Targeted | Oral Delivery | Scalable
Conventional Approaches
Limited targeting / Liver accumulation
Off-target effects / immunogenicity
IV injection
Single therapy payload / non versatile
Manufacturing & scalability complexity
VS
Engineered Plant-Derived Exosomes
Targeted tumor delivery
Non toxic / non immunogenic
Oral administration
High loading capacity / versatile loading
Reproducible & scalable
PLATFORM POTENTIAL
One Delivery Platform
Multiple Payloads & Therapeutic Opportunities
Today
KRAS Mutated Colorectal & Lung Cancers (all mutations)
.png)

Tomorrow
Additional Oncology Indications
Delivery Platform Expansion
.png)
bottom of page
